Literature DB >> 17652892

Impact of delta-sarcoglycan gene polymorphism on the occurrence of coronary spastic angina in Japanese patients with hypertrophic cardiomyopathy.

Tsuyoshi Honda1, Seigo Sugiyama, Tomohiro Sakamoto, Koichi Kaikita, Hisao Ogawa.   

Abstract

BACKGROUND: Patients with hypertrophic cardiomyopathy (HCM) frequently complain of angina-like symptoms in the absence of organic coronary stenoses. Coronary spasm might cause myocardial ischemia in HCM patients. Delta-sarcoglycan plays a crucial role in the pathogenesis of HCM and coronary spasm in a mouse model. METHODS AND
RESULTS: This is a retrospective, single-center study with a small sample size. Seventy patients with HCM underwent coronary angiography and received acetylcholine provocation test. Coronary risk factors and 5'-untranslated region (UTR) G to C polymorphism on delta-sarcoglycan gene (n=64) were evaluated in the HCM patients. In 31 (44.3%) of 70 HCM patients, coronary spasm was induced by the provocation. None of the coronary risk factors was significantly different between the coronary spasm group and the non-coronary spasm group. The 5'-UTR gene polymorphism was associated with the occurrence of coronary spasm with an additive effect on the coexistence (p=0.025). Multiple logistic regression analysis showed that the C allele of 5'-UTR polymorphism was a significant risk factor for coronary spasm in patients with HCM (odds ratio, 3.1; 95% confidence interval, 1.0 to 9.5; p=0.045) that was independent of traditional coronary risk factors.
CONCLUSIONS: The 5'-UTR polymorphism on delta-sarcoglycan gene was associated with coronary spasm in Japanese patients with HCM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17652892     DOI: 10.1253/circj.71.1263

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  6 in total

1.  A delta-sarcoglycan gene polymorphism as a risk factor for hypertrophic cardiomyopathy.

Authors:  Rosa M Ordoñez-Razo; Martín H Garrido-Garduño; Ramón A Pérez-Martínez; Victor M Ruiz; Esteban Herrera-Tepatlán; Maricela Rodríguez-Cruz; Ana L Jiménez-Vaca; Fernando Minauro-Sanmiguel; Fabio A Salamanca-Gómez
Journal:  Genet Test Mol Biomarkers       Date:  2012-04-23

2.  Dilated cardiomyopathy mutations in δ-sarcoglycan exert a dominant-negative effect on cardiac myocyte mechanical stability.

Authors:  Matthew D Campbell; Marc Witcher; Anoop Gopal; Daniel E Michele
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-03-11       Impact factor: 4.733

3.  δ-Sarcoglycan-deficient muscular dystrophy: from discovery to therapeutic approaches.

Authors:  Alison M Blain; Volker W Straub
Journal:  Skelet Muscle       Date:  2011-03-17       Impact factor: 4.912

4.  The CC genotype of the delta-sarcoglycan gene polymorphism rs13170573 is associated with obstructive sleep apnea in the Chinese population.

Authors:  Rensong Ye; Wenlan Yang; Yiming Yuan; Xingqi Deng
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

5.  A Haplotype of Two Novel Polymorphisms in δ-Sarcoglycan Gene Increases Risk of Dilated Cardiomyopathy in Mongoloid Population.

Authors:  Jie Chen; Ye Jin; Hong Wang; Sisi Wei; Dan Chen; Li Ying; Qing Zhou; Gang Li; Joyce Li; Jimin Gao; Naoya Kato; Wei Hu; Yigang Li; Yuepeng Wang
Journal:  PLoS One       Date:  2015-12-31       Impact factor: 3.240

6.  Genetic Loci and Novel Discrimination Measures Associated with Blood Pressure Variation in African Americans Living in Tallahassee.

Authors:  Jacklyn Quinlan; Laurel N Pearson; Christopher J Clukay; Miaisha M Mitchell; Qasimah Boston; Clarence C Gravlee; Connie J Mulligan
Journal:  PLoS One       Date:  2016-12-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.